Ingredient or product comparison
Peptides for Hair Loss Compared — GHK-Cu vs TB-500 vs BPC-157
A 2022 study published in the International Journal of Molecular Sciences found that GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) increased hair follicle size by 58% and stimulated keratinocyte proliferation. But only when applied at concentrations above
This source-based comparison does not add ratings or recommend a winner.
- A 2022 study published in the International Journal of Molecular Sciences found that GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) increased hair follicle size by 58% and stimulated keratinocyte proliferation. But only when applied at concentrations above 1μM. Below that threshold, the peptide showed no measurable effect on follicular activity. This isn't an outlier finding. Most peptides marketed for hair restoration work through narrow, concentration-dependent pathways that require precision dosing to produce any clinical outcome. The problem: most commercial formulations never disclose concentration, carrier selection, or whether the peptide they're selling can even penetrate the dermal layer at the dose provided.
- We've worked with research teams evaluating peptide efficacy across androgenetic alopecia, telogen effluvium, and alopecia areata. The gap between what peptides can do in controlled conditions and what they deliver in real-world use comes down to three things: the specific peptide chosen, the delivery vehicle, and whether the formulation was designed around the biological target or around a price point.
- What are peptides for hair loss and how do they work?
- Peptides for hair loss are short chains of amino acids (typically 2–50 residues) that signal specific cellular responses in the hair follicle microenvironment. Stimulating stem cell differentiation, modulating inflammation, or extending the anagen growth phase. Unlike minoxidil (a vasodilator) or finasteride (a 5-alpha reductase inhibitor), peptides act as biological messengers that target follicular keratinocytes, dermal papilla cells, and perifollicular vasculature directly. Efficacy depends entirely on molecular weight, amino acid sequence, and whether the peptide reaches the hair bulb at therapeutic concentration. Which most over-the-counter serums do not achieve.
- Yes, certain peptides demonstrate measurable follicular activity in clinical research. But the three peptides with the most documented mechanisms (GHK-Cu, TB-500, BPC-157) work through entirely different pathways. GHK-Cu acts as a copper chaperone that activates lysyl oxidase and superoxide dismutase. Enzymes critical for collagen cross-linking and oxidative stress reduction in aging follicles. TB-500 (Thymosin Beta-4) modulates actin polymerisation, which extends the anagen phase and delays follicular miniaturisation. BPC-157 reduces inflammatory cytokines (TNF-alpha, IL-6) that constrict perifollicular capillaries and accelerate telogen shift. Most product comparisons treat all three as interchangeable 'hair growth peptides'. They're not. This article covers the specific mechanisms of each peptide, the evidence base for follicular outcomes, and what formulation variables determine whether a peptide product works or wastes money.